LMQ.F OXFORD BIODYNAMICS LS-01

Healthcare Diagnostics & Research Frankfurt Exchange
0.0005 EUR
Close of Nov 12, 2026
0.0005 0.0055
Market cap
EUR 6.72M
P/E
-
P/B
1.73x
ROE
-999.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Sep 2025.

Is LMQ.F undervalued?

Graham number

The Graham number of OXFORD BIODYNAMICS LS-01 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

OXFORD BIODYNAMICS LS-01 fundamental analysis

No fundamental analysis for OXFORD BIODYNAMICS LS-01 yet.

OXFORD BIODYNAMICS LS-01 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About OXFORD BIODYNAMICS LS-01

Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United Kingdom. The company provides EpiSwitch CiRT (Checkpoint inhibitor Response Test), a blood test that predicts an individual patient's therapeutic response to checkpoint inhibitor immunotherapy. EpiSwitch, a proprietary technology platform that enables screenin…

Full company profile